SAT0681 Risk of active tuberculosis in patients with inflammatory arthritis receiving tnf-inhibitors
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.5835
Abstract: Background Tuberculosis (TB) is a major concern in patients receiving TNF inhibitors (TNFi). Objectives To assess the incidence of active TB and the efficacy of TB prevention measures in a large, single-center cohort of patients… read more here.
Keywords: roche ucb; none declared; pfizer; abbvie msd ... See more keywords